Masashi Adachi

9.7k total citations · 2 hit papers
83 papers, 8.1k citations indexed

About

Masashi Adachi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Masashi Adachi has authored 83 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 34 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Masashi Adachi's work include Drug Transport and Resistance Mechanisms (15 papers), Cell Adhesion Molecules Research (11 papers) and Cell death mechanisms and regulation (10 papers). Masashi Adachi is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Cell Adhesion Molecules Research (11 papers) and Cell death mechanisms and regulation (10 papers). Masashi Adachi collaborates with scholars based in Japan, United States and Netherlands. Masashi Adachi's co-authors include Shigekazu Nagata, Rie Watanabe‐Fukunaga, Takashi Suda, Jun Ogasawara, Masayuki Miyake, Tsutomu Kasugai, Naoto Itoh, Yukihiko Kitamura, Akio Matsuzawa and John D. Schuetz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Masashi Adachi

82 papers receiving 7.9k citations

Hit Papers

Lethal effect of the anti-Fas antibody in mice 1993 2026 2004 2015 1993 1998 500 1000 1.5k

Peers

Masashi Adachi
Martin Sattler United States
William S. Dalton United States
Thomas Rutherford United States
Steven J. Harper United Kingdom
Samuel C. Mok United States
Martin Sattler United States
Masashi Adachi
Citations per year, relative to Masashi Adachi Masashi Adachi (= 1×) peers Martin Sattler

Countries citing papers authored by Masashi Adachi

Since Specialization
Citations

This map shows the geographic impact of Masashi Adachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Adachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Adachi more than expected).

Fields of papers citing papers by Masashi Adachi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Adachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Adachi. The network helps show where Masashi Adachi may publish in the future.

Co-authorship network of co-authors of Masashi Adachi

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Adachi. A scholar is included among the top collaborators of Masashi Adachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Adachi. Masashi Adachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Masahiko, Tomoaki Oda, Masashi Adachi, et al.. (2020). Partial silencing of fucosyltransferase 8 gene expression inhibits proliferation of Ishikawa cells, a cell line of endometrial cancer. Biochemistry and Biophysics Reports. 22. 100740–100740. 12 indexed citations
2.
Takenaka, Kazumasa, James P. Morgan, George L. Scheffer, et al.. (2007). Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution. Cancer Research. 67(14). 6965–6972. 73 indexed citations
3.
Ogawa, Eiji, Kazumasa Takenaka, Hiromichi Katakura, et al.. (2007). Perimembrane Aurora-A Expression is a Significant Prognostic Factor in Correlation with Proliferative Activity in Non-Small-Cell Lung Cancer (NSCLC). Annals of Surgical Oncology. 15(2). 547–554. 58 indexed citations
4.
Mennone, Albert, Carol J. Soroka, Shi‐Ying Cai, et al.. (2006). Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology. 43(5). 1013–1021. 138 indexed citations
5.
Imaoka, Tomoki, Hiroyuki Kusuhara, Masashi Adachi, et al.. (2006). Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir. Molecular Pharmacology. 71(2). 619–627. 221 indexed citations
6.
Adachi, Masashi. (2006). The Trends in Family Communication Studies. Kazoku syakaigaku kenkyu. 18(1). 40–45.
7.
Hasegawa, Maki, Hiroyuki Kusuhara, Masashi Adachi, et al.. (2006). Multidrug Resistance–Associated Protein 4 Is Involved in the Urinary Excretion of Hydrochlorothiazide and Furosemide. Journal of the American Society of Nephrology. 18(1). 37–45. 97 indexed citations
8.
Katakura, Hiromichi, Kazumasa Takenaka, Masatsugu Nakagawa, et al.. (2006). Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Lung Cancer. 51(3). 323–328. 21 indexed citations
9.
Takenaka, Kazumasa, Hiromichi Katakura, Fengshi Chen, et al.. (2006). The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Cancer Letters. 246(1-2). 34–40. 8 indexed citations
10.
Leggas, Markos, Masashi Adachi, George L. Scheffer, et al.. (2004). Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy. Molecular and Cellular Biology. 24(17). 7612–7621. 321 indexed citations
11.
Ikeda, Naoya, Masashi Adachi, Toshihiko Taki, et al.. (1999). Prognostic significance of angiogenesis in human pancreatic cancer. British Journal of Cancer. 79(9-10). 1553–1563. 267 indexed citations
12.
Kawane, Kohki, Hidehiro Fukuyama, Masashi Adachi, et al.. (1999). Structure and promoter analysis of murine CAD and ICAD genes. Cell Death and Differentiation. 6(8). 745–752. 29 indexed citations
13.
Okabe, Taijiro, R. Takayanagi, Masashi Adachi, Kyosuke Imasaki, & H Nawata. (1998). Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells. Journal of Endocrinology. 156(1). 169–175. 38 indexed citations
14.
Higashiyama, Masahiko, Ken Kodama, Hideoki Yokouchi, et al.. (1998). KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor. Cancer. 83(3). 466–474. 45 indexed citations
15.
Higashiyama, Masahiko, Osamu Doi, Masashi Adachi, et al.. (1997). Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. International Journal of Cancer. 74(2). 205–211. 44 indexed citations
16.
Adachi, Masashi, Sachiko Suematsu, Tôru Kondo, et al.. (1995). Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genetics. 11(3). 294–300. 312 indexed citations
17.
Ueo, Hiroaki, Masayuki Honda, Masashi Adachi, et al.. (1994). Minimal increase in serum interleukin-6 levels during laparoscopic cholecystectomy. The American Journal of Surgery. 168(4). 358–360. 52 indexed citations
18.
Ogasawara, Jun, Rie Watanabe‐Fukunaga, Masashi Adachi, et al.. (1993). Lethal effect of the anti-Fas antibody in mice. Nature. 364(6440). 806–809. 1642 indexed citations breakdown →
19.
Arinaga, Shinya, Masashi Adachi, Hiroshi Inoue, et al.. (1993). Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C. Cancer Immunology Immunotherapy. 37(4). 220–226. 3 indexed citations
20.
Ryo, Ryukichi, Wataru Sugano, Katsuyasu Saigo, et al.. (1992). Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen‐induced platelet aggregation. American Journal of Hematology. 39(1). 25–31. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026